Furthermore, calreticulin exposure on malignant AML blasts is correlated with increased frequency of T lymphocytes and improved survival—a finding that complements TRAIL+ iNKT cells’ killing of AML cells, although in this cohort of AML patients iNKT cells were not investigated (108). This evidence concerns the gene TNFSF10 and acute myeloid leukemia.